Nuclear receptor subfamily 0 group B member 1 (NR0B1)

Nuclear receptor subfamily 0 group B member 1 (NR0B1, commonly known as DAX-1) is an atypical orphan nuclear receptor that acts predominantly as a transcriptional repressor within the nuclear receptor superfamily[1][5]. It lacks a conventional DNA-binding domain but possesses a unique N-terminal repeat structure and a C-terminal ligand-binding domain. DAX-1 regulates gene expression by repressing the activity of other nuclear receptors, such as steroidogenic factor 1 (SF-1), and is critical for the development and function of adrenal glands, hypothalamus, pituitary, and gonads[1][2][5][7]. Mutations in NR0B1 cause X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, underscoring its essential role in endocrine homeostasis, steroidogenesis, and sexual differentiation[1][2][3][4][5]. Despite being a pivotal regulator, NR0B1/DAX-1 is not currently the target of approved drugs, but its status as a master transcriptional repressor highlights its potential relevance for endocrine and developmental disorders.

Other names

DAX-1DAX1AHCAHCHAHXDSSGTDHHGNROB1SRXY2Adrenal hypoplasia congenita critical region on the X chromosome protein 1Nuclear receptor DAX-1Dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1

Not applicable (no drugs established); as a drug target, hypothetical mechanisms would involve modulation of its repressor activity on steroidogenic transcription factors (e.g., SF-1 repression)[3][7]